Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Pilotto

Showing results (31-40 of 228) with videos related to

Pageof 23
Sort By:
Cancers|January 20, 2018
mTOR Cross-Talk in Cancer and Potential for Combination TherapyFabiana Conciatori, Ludovica Ciuffreda, Chiara Bazzichetto, et al.
Patient Education and Counseling|February 5, 2022
Exercise oncology: It is time to make a changeAlice Avancini, Lorenzo Belluomini, Daniela Tregnago, et al.
JCO Precision Oncology|January 20, 2022
<i>HER2</i> Aberrations in NSCLC: So Close Yet So FarGiulia Sartori, Lorenzo Belluomini, Rosalinda Trovato, et al.
Expert Review of Anticancer Therapy|May 11, 2021
A multimodal approach to cancer-related cachexia: from theory to practiceAlice Avancini, Ilaria Trestini, Daniela Tregnago, et al.
Translational Lung Cancer Research|February 2, 2019
Exploiting <i>MET</i> dysregulation in <i>EGFR</i>-addicted non-small-cell lung carcinoma: a further step toward personalized medicineVincenzo Di Noia, Ettore D'Argento, Sara Pilotto, et al.
Immunotherapy|June 28, 2021
Abscopal effect and resistance reversion in nivolumab-treated non-small-cell lung cancer undergoing palliative radiotherapy: a case reportFrancesco Fiorica, Lorenzo Belluomini, Jacopo Giuliani, et al.
International Journal of Molecular Sciences|August 22, 2018
Role of mTOR Signaling in Tumor Microenvironment: An OverviewFabiana Conciatori, Chiara Bazzichetto, Italia Falcone, et al.
Ebiomedicine|October 2, 2015
Deciphering Crosstalk Circuits in Non-small Cell Lung Cancers with an Increasing Interval Length of Low Dose CT ScreeningRafael Rosell, Niki Karachaliou, Imane Chaib, et al.
Targeted Oncology|January 29, 2013
Clinical meta-analyses of targeted therapies in adenocarcinomaEmilio Bria, Maria Bonomi, Sara Pilotto, et al.
Expert Review of Clinical Pharmacology|May 4, 2026
Immunotherapy in limited-stage small cell lung cancer: riding the ADRIATIC wave toward precisionSerena Eccher, Adele Bonato, Marco Sposito, et al.
Pageof 23

Showing results (31-40 of 228) with videos related to

Sort By:
Pageof 23
Cancers|January 20, 2018
mTOR Cross-Talk in Cancer and Potential for Combination TherapyFabiana Conciatori, Ludovica Ciuffreda, Chiara Bazzichetto, et al.
Patient Education and Counseling|February 5, 2022
Exercise oncology: It is time to make a changeAlice Avancini, Lorenzo Belluomini, Daniela Tregnago, et al.
JCO Precision Oncology|January 20, 2022
<i>HER2</i> Aberrations in NSCLC: So Close Yet So FarGiulia Sartori, Lorenzo Belluomini, Rosalinda Trovato, et al.
Expert Review of Anticancer Therapy|May 11, 2021
A multimodal approach to cancer-related cachexia: from theory to practiceAlice Avancini, Ilaria Trestini, Daniela Tregnago, et al.
Translational Lung Cancer Research|February 2, 2019
Exploiting <i>MET</i> dysregulation in <i>EGFR</i>-addicted non-small-cell lung carcinoma: a further step toward personalized medicineVincenzo Di Noia, Ettore D'Argento, Sara Pilotto, et al.
Immunotherapy|June 28, 2021
Abscopal effect and resistance reversion in nivolumab-treated non-small-cell lung cancer undergoing palliative radiotherapy: a case reportFrancesco Fiorica, Lorenzo Belluomini, Jacopo Giuliani, et al.
International Journal of Molecular Sciences|August 22, 2018
Role of mTOR Signaling in Tumor Microenvironment: An OverviewFabiana Conciatori, Chiara Bazzichetto, Italia Falcone, et al.
Ebiomedicine|October 2, 2015
Deciphering Crosstalk Circuits in Non-small Cell Lung Cancers with an Increasing Interval Length of Low Dose CT ScreeningRafael Rosell, Niki Karachaliou, Imane Chaib, et al.
Targeted Oncology|January 29, 2013
Clinical meta-analyses of targeted therapies in adenocarcinomaEmilio Bria, Maria Bonomi, Sara Pilotto, et al.
Expert Review of Clinical Pharmacology|May 4, 2026
Immunotherapy in limited-stage small cell lung cancer: riding the ADRIATIC wave toward precisionSerena Eccher, Adele Bonato, Marco Sposito, et al.
Pageof 23